A PhD student in the Department of Chemistry, University of Ilorin, Misitura Arowona, has developed a drug that promises to be potent in the treatment of tuberculosis, an infectious disease that usually attacks the lungs.According to the publication, the metal attached anti-TB drug developed by Arowona, has improved the efficiency of the anti-TB drugs compared to normal drugs that are consumed globally.
“It is estimated that about 407, 000 people in Nigeria have TB in a year,” it said.
The publication explained that Arowona, who is in Vadodara for a year-long project, said, “Earlier studies have proved that when a metal is attached with a pharmaceutical, it increases the efficacy of the drug.
“Taking a cue from cisplatin, an anti-cancer drug, whose efficacy improved after applying platinum as metal, the scholar worked on multiple metal-based drugs to see whether the efficiency of anti-TB drugs can be increased by attaching metals to it”.
Also quoting a Professor of Chemistry, Rajendrasinh Jadeja, of Sayajirao University, India, the Nigerian scholar used metals like ion, cobalt, copper and zinc to prepare the metallodrugs.
“The drugs, which have been developed, include ciprofloxacin HCl, ofloxacin, pyrazinamide and moxifloxacin HCl. Presently, there is no metal-based anti-TB drug available in the market.
“When we compared the metallodrugs with the original anti-TB drugs, the metallodrugs were more effective.
“Also, we found that of all the metallodrugs, the copper complex of ciprofloxacin is most effective.”
Source: Punch
